Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In silico CD4 + T-cell multiepitope prediction and HLA distribution analysis for Marburg Virus—A strategy for vaccine designing

Journal of King Saud University - Science(2021)10.1016/j.jksus.2021.101751Source: DataRank Database

In silico CD4 + T-cell multiepitope prediction and HLA distribution analysis for Marburg Virus—A strategy for vaccine designing is a research paper published in Journal of King Saud University - Science (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.06)OA: hybridTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Swati Dhasmana,Ahmad Alsulimani ORCID,Sudhir Kotnala ORCID,Vivek K. Kashyap ORCID,Shafiul Haque ORCID

Live enrichment

PubMed:38881729 PMC:PMC11178283 OpenAlex:https://openalex.org/W4200617498

National Cancer Institute

Grant: R01 CA204552

National Cancer Institute

Grant: R01 CA206069

National Cancer Institute

Grant: R01 CA210192

National Institutes of Health

Grant: 5R01CA204552-03

MUC13 Mucin in Colorectal Cancer Health Disparity

National Institutes of Health

Grant: 7R01CA210192-05

Targeted Nanotherapy for Pancreatic Cancer

National Institutes of Health

Grant: 1R01CA206069-01A1

Development of Targeted Nanotechnology Platform for Pancreatic Cancer

National Institutes of Health

University of Texas Rio Grande Valley

FWCI

0.06

Citation Percentile

0.4%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.jksus.2021.101751

publisherhttps://doi.org/10.1016/j.jksus.2021.101751

publisherhttps://api.elsevier.com/content/article/PII:S1018364721004134?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1018364721004134?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38881729

Fields of Study

Viral Infections and Outbreaks Researchvaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 Research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

In silicoVirologyBiologyHuman leukocyte antigenComputational biologyMarburg virusVirusAntigenGeneticsEbola virusGeneAntigenicCd4+ T CellNon-mutagenicPeptide Based VaccineNon-toxic And High World Population CoverageArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being